Special Issue "Therapeutic Efficiency of Phyto-Molecules"

Submission Deadline: 02 February 2022
Submit to Special Issue
Guest Editors
Dr. Kandasamy Saravanakumar, Kangwon National University, Korea
Dr. Myeong-Hyeon Wang, Kangwon National University, Korea
Dr. Veeraraghavan Vishnu Priya, Saveetha University, India


The new viral, bacterial and fungal pathogens are currently developing resistance to several available drugs. Newly discovered drugs like compounds are more virulent to inhibiting the viral or microbial pathogens related diseases and cancer cells in vitro but is not successful in the host due to less stability and inability to targeting the pathogenic location. Therefore, discovery of the novel drugs is important and by the way development of novel strategies to enhance its therapeutic efficiency also is essential. Therefore, proper understating of the new compounds characteristics and its chemistry can enable us to develop the novel drug carrier system to improve its therapeutic efficiency. Hence, this special issue in aims to focusing the isolation of novel metabolites from the plant resources and increasing its stability and targeted delivery by using the nano-drug carrier delivery system (nDDS). Further evaluating the therapeutic efficiency of drug loaded nDDS in host level by animal experiments, including the following but not limited in scope to:

1. Bioactive compounds

2. Methods in isolation of novel compounds

3. Chromatography techniques in compounds purification

4. nDDS for improving therapeutic efficiency of natural compounds  

5. Nanotechnology advances for medicinal natural product research

Medicinal Plant Extracts, Antioxidants, Enzyme Inhibitors, Nanoparticles from Natural Products

Published Papers
  • Potential Antidiabetic and Anti-Genotoxic Activities of Silver Nanoparticles of Alkaloid Extract of Rhazya stricta in Rat Animal Model
  • Abstract In most of Arabian courtiers Rhazya stricta is extensively utilized in public medicine for several diseases treatment. In this study, crude alkaloid extract of R. stricta (CAERS) coated with silver nanoparticles (CAERS-AgNPs) as potential treatment against diabetes in DM animal model was evaluated. Swiss albino male rats (n = 80) were injected with STZ to induce Diabetes Mellitus type-2 (DM). DM-rats were injected different doses of CAERS or CAERS-nanoparticles (CAERS-NPs) for 2 months. The results exhibited that mRNA expression of insulin and insulin receptor was down-regulated, activity levels of antioxidant enzymes were decreased, generation of ROS mediated DNA adducts and apoptosis in… More
  •   Views:444       Downloads:419        Download PDF